breakout, page-49

I agree with cb - the 2 things we were after is a go ahead and finding out what was the best dose.

We got what we wanted, and this should put them in a good shape with regards to a deal with a big pharma.

In fact, they couldn't be in a better shape - successful capital raising and positive phase III results.

Which is why I have to admit that I am bit surprised that in a global positive environment the sp hasn't gone up on the basis that the market expects a deal to take place in the near future. Seems like the market is really struggling to gain confidence in this stock, it is like they want to see the agreement before getting excited - and nothing else would work, not good phase III results or any other rumour.

I keep holding ... but, with this stock, all the long term shareholders will have deserved every $ of their profit - should they make one.